March 25, 2017
Recommended Topic Related To:

Lupron Depot 22.5

"The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prost"...

A A A

Lupron Depot 22.5




PATIENT INFORMATION

An information pamphlet for patients is included with the product.

Last reviewed on RxList: 1/13/2017
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.